CY1107598T1 - Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωα - Google Patents
Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωαInfo
- Publication number
- CY1107598T1 CY1107598T1 CY20071100394T CY071100394T CY1107598T1 CY 1107598 T1 CY1107598 T1 CY 1107598T1 CY 20071100394 T CY20071100394 T CY 20071100394T CY 071100394 T CY071100394 T CY 071100394T CY 1107598 T1 CY1107598 T1 CY 1107598T1
- Authority
- CY
- Cyprus
- Prior art keywords
- agents
- analgesics
- hepatitis
- protection
- catabolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με συνθέσεις για την προστασία, θεραπεία και επιδιόρθωση συνδετικών ιστών σε ανθρώπους και ζώα που περιλαμβάνουν οποιοδήποτε ή όλα από αναβολικούς, αντι-καταβολικούς, αντι-οξειδωτικούς και αναλγητικούς παράγοντες, που περιλαμβάνουν αμινοσάκχαρα, S-αδενοσυλομεθειονίνη, αραχαδονικό οξύ, GAGs, που περιλαμβάνουν πεντοσάνη, κολλαγόνο τύπου II, τετρακυκλίνες ή προσομοιάζουσες τετρακυκλίνη ενώσεις, diacerin, υπεροξειδική δισμουτάση, L-εργοθειονίνη, ένα ή περισσότερα μη-σαπωνοποιήσιμα αβοκάντο/σόγιας, υδροξυπρολίνη και ένα αναλγητικό, π.χ., ακεταμινοφαίνη, και με μεθόδους θεραπείας ανθρώπων και ζώων με χορήγηση αυτών των καινοφανών συνθέσεων σε ανθρώπους και ζώα που τις έχουν ανάγκη.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8820598P | 1998-06-05 | 1998-06-05 | |
US09/249,335 US6451771B1 (en) | 1999-02-12 | 1999-02-12 | Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals |
US27488199A | 1999-03-23 | 1999-03-23 | |
EP99927137A EP1083929B1 (en) | 1998-06-05 | 1999-06-03 | The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107598T1 true CY1107598T1 (el) | 2013-03-13 |
Family
ID=27375912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100394T CY1107598T1 (el) | 1998-06-05 | 2007-03-20 | Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωα |
Country Status (12)
Country | Link |
---|---|
US (2) | US8846118B2 (el) |
EP (2) | EP2272535A1 (el) |
JP (1) | JP4739522B2 (el) |
AT (1) | ATE353671T1 (el) |
AU (2) | AU770010B2 (el) |
CA (1) | CA2333755C (el) |
CY (1) | CY1107598T1 (el) |
DE (1) | DE69935140T2 (el) |
DK (1) | DK1083929T3 (el) |
ES (1) | ES2278447T3 (el) |
PT (1) | PT1083929E (el) |
WO (1) | WO1999062459A2 (el) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
DE50016101D1 (de) | 1999-08-13 | 2011-06-09 | Curadis Gmbh | Substanzen und mittel zur positiven beeinflussung von kollagen |
DE20004010U1 (de) | 2000-03-02 | 2000-06-21 | Febena Pharma GmbH, 50825 Köln | Diätische Zusammensetzung mit einem Gehalt an Glycosaminoglycanen |
FR2813195B1 (fr) | 2000-08-29 | 2003-04-04 | Serobiologiques Lab Sa | Utilisation d'extraits de la plante cassia alata dans des produits de soin |
US7138386B2 (en) | 2001-01-05 | 2006-11-21 | Kyowa Hakko Kogyo Co., Ltd. | Preventives or remedies for arthritis |
WO2002098449A1 (fr) * | 2001-06-01 | 2002-12-12 | Nippon Meat Packers, Inc. | Medications pour lesions des articulations et aliments fonctionnels |
US7285570B2 (en) * | 2003-04-17 | 2007-10-23 | The Procter & Gamble Company | Compositions and methods for regulating mammalian keratinous tissue |
CN101795704B (zh) * | 2007-06-01 | 2014-07-30 | 协和发酵生化株式会社 | 经口组合物 |
WO2010146078A2 (en) * | 2009-06-16 | 2010-12-23 | Bergen Teknologioverføring As | Novel uses of hydroxyproline compositions |
US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
US9421234B2 (en) * | 2011-05-20 | 2016-08-23 | Nutramax Laboratories, Inc. | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration |
US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
EP3269372B1 (en) * | 2012-01-19 | 2019-06-12 | Hybrid Medical, LLC | Topical therapeutic formulations |
US10471131B2 (en) | 2012-01-19 | 2019-11-12 | Hybrid Medical, Llc | Topical therapeutic formulations |
US9231977B2 (en) * | 2013-12-23 | 2016-01-05 | Nokia Technologies Oy | Method and apparatus for providing collaborative privacy policies for a shared device |
US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB856493A (en) * | 1957-10-04 | 1960-12-21 | Pfizer & Co C | Therapeutic compositions comprising tetracycline antibiotics |
FR2193M (fr) * | 1962-09-10 | 1963-12-09 | Lipha | Nouveau médicament pour le traitement des maladies infectieuses. |
IT1137640B (it) * | 1981-08-24 | 1986-09-10 | Bioresearch Srl | Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo |
US4808576A (en) * | 1986-04-28 | 1989-02-28 | Mobay Corporation | Remote administration of hyaluronic acid to mammals |
EP0662838A4 (en) * | 1992-09-25 | 1996-07-24 | Autoimmune Inc | PROCESS FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS WITH TYPE II COLLAGEN. |
US5364845C1 (en) * | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
US5637616A (en) * | 1993-06-18 | 1997-06-10 | Arcturus Pharmaceutical Corporation | Method for treating diseases mediated by proteases |
US5827874A (en) | 1995-05-05 | 1998-10-27 | Meyer; Hans | Methods of treating pain and inflammation with proline |
US6255295B1 (en) * | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
FR2770777B1 (fr) * | 1997-11-10 | 2000-02-25 | Fabre Pierre Dermo Cosmetique | Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie |
US6797289B2 (en) * | 1998-02-13 | 2004-09-28 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
-
1999
- 1999-06-03 WO PCT/US1999/012152 patent/WO1999062459A2/en active IP Right Grant
- 1999-06-03 AT AT99927137T patent/ATE353671T1/de active
- 1999-06-03 DK DK99927137T patent/DK1083929T3/da active
- 1999-06-03 PT PT99927137T patent/PT1083929E/pt unknown
- 1999-06-03 EP EP10184786A patent/EP2272535A1/en not_active Ceased
- 1999-06-03 JP JP2000551719A patent/JP4739522B2/ja not_active Expired - Lifetime
- 1999-06-03 ES ES99927137T patent/ES2278447T3/es not_active Expired - Lifetime
- 1999-06-03 AU AU44115/99A patent/AU770010B2/en not_active Expired
- 1999-06-03 EP EP99927137A patent/EP1083929B1/en not_active Revoked
- 1999-06-03 DE DE69935140T patent/DE69935140T2/de not_active Expired - Lifetime
- 1999-06-03 CA CA2333755A patent/CA2333755C/en not_active Expired - Lifetime
-
2007
- 2007-03-20 CY CY20071100394T patent/CY1107598T1/el unknown
-
2008
- 2008-08-21 US US12/230,001 patent/US8846118B2/en not_active Expired - Fee Related
-
2009
- 2009-06-05 AU AU2009202256A patent/AU2009202256B2/en not_active Expired
- 2009-09-24 US US12/566,449 patent/US8753697B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1083929A4 (en) | 2002-11-27 |
ATE353671T1 (de) | 2007-03-15 |
JP4739522B2 (ja) | 2011-08-03 |
AU2009202256B2 (en) | 2011-09-22 |
CA2333755C (en) | 2012-11-27 |
US8846118B2 (en) | 2014-09-30 |
JP2002516829A (ja) | 2002-06-11 |
DE69935140D1 (de) | 2007-03-29 |
EP1083929B1 (en) | 2007-02-14 |
DE69935140T2 (de) | 2007-05-31 |
WO1999062459A3 (en) | 2000-02-24 |
WO1999062459A9 (en) | 2000-04-27 |
CA2333755A1 (en) | 1999-12-09 |
US8753697B2 (en) | 2014-06-17 |
US20100105632A1 (en) | 2010-04-29 |
AU770010B2 (en) | 2004-02-12 |
EP2272535A1 (en) | 2011-01-12 |
AU4411599A (en) | 1999-12-20 |
EP1083929A2 (en) | 2001-03-21 |
ES2278447T3 (es) | 2007-08-01 |
AU2009202256A1 (en) | 2009-07-02 |
WO1999062459A2 (en) | 1999-12-09 |
DK1083929T3 (da) | 2007-06-11 |
US20090087503A1 (en) | 2009-04-02 |
PT1083929E (pt) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107598T1 (el) | Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωα | |
FI954654A (fi) | Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen | |
WO1998022034A3 (en) | Interventional photonic energy emitter system | |
DK0413528T3 (da) | Amphotere præparater og polymere former af alphahydroxysyrer og deres terapeutiske anvendelse | |
ATE415887T1 (de) | Therapeutische vorrichtung | |
DE69530926D1 (de) | Mittel zur förderung des haarwachstums | |
BR9509858A (pt) | Sistema de restauração de ligamento e tend o | |
DK0563265T3 (da) | Orale præparater | |
CA2001754A1 (en) | Glucan dietary additives | |
DK0781547T3 (da) | Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi | |
BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
NO20004282D0 (no) | Matriksproteinpreparater for sÕrheling | |
ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
DE69711649D1 (de) | P1, p4-dithio-p2,p3-monochloromethylen 5',5'''-diadenosin-p1,p4-tetraphosphat verwendet als anti-thrombose mittel | |
ZA898440B (en) | Lactamimides in the treatment of drug-resistant protozoal infections | |
ITTO940197A0 (it) | Cannula per trattamenti di liposuzione e manipolo utilizzante tale cannela | |
CA2322878A1 (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
DE69526350D1 (de) | Abschuppungs-zusammensetzung | |
ES2058451T3 (es) | Un metodo para la preparacion de una composicion farmaceutica. | |
ES2069823T3 (es) | Tratamiento de la hipertension ocular con una combinacion sinergica ocular. | |
MXPA01011924A (es) | Metodos y composiciones para modular la respuesta inmunitaria y para el tratamiento de trastornos inflamatorios. | |
ES2104223T3 (es) | 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. | |
IT233619Y1 (it) | dispositivo medicale per la protezione asettica della estremita' di connessione di linee impiantate su pazienti. | |
RU96113185A (ru) | Раствор для лечения заболеваний и повреждений роговицы "кератан-с" |